BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12442660)

  • 21. [The origin of Parkinson's disease].
    Rinne J
    Duodecim; 1997; 113(18):1819-24. PubMed ID: 10892075
    [No Abstract]   [Full Text] [Related]  

  • 22. Programmed cell death and Parkinson's disease.
    Burke RE
    Mov Disord; 1998; 13 Suppl 1():17-23. PubMed ID: 9613714
    [No Abstract]   [Full Text] [Related]  

  • 23. Biochemical aspects of Parkinson's disease.
    Nagatsu T
    Adv Neurol; 1993; 60():165-74. PubMed ID: 8093575
    [No Abstract]   [Full Text] [Related]  

  • 24. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology.
    Bartels AL; Leenders KL
    Cortex; 2009 Sep; 45(8):915-21. PubMed ID: 19095226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A new history of basal ganglia and physiopathology of Parkinson's disease].
    Reinoso Suárez F
    An R Acad Nac Med (Madr); 2001; 118(4):771-88; discussion 788-92. PubMed ID: 12056254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new sensitive imaging biomarker for Parkinson disease?
    Lang AE; Mikulis D
    Neurology; 2009 Apr; 72(16):1374-5. PubMed ID: 19129504
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neural mechanisms for the clinical syndromes of Parkinson's disease].
    Kato M
    Nihon Rinsho; 1997 Jan; 55(1):26-31. PubMed ID: 9014419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The basal ganglia in extrapyramidal dysfunction.
    Barnes CD
    Brain Res Bull; 1983 Aug; 11(2):271-5. PubMed ID: 6226339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal ganglia and Parkinson's disease: neurobiological and pharmacological aspects in animals and man.
    Cools AR
    Clin Neurol Neurosurg; 1984; 86(3):178-95. PubMed ID: 6091966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Basal ganglia lesions and neurotransmitters].
    Yoshida M
    Nihon Rinsho; 1978; 36(1):58-64. PubMed ID: 24766
    [No Abstract]   [Full Text] [Related]  

  • 32. The search for a role of the caudal intralaminar nuclei in the pathophysiology of Parkinson's disease.
    Lanciego JL; López IP; Rico AJ; Aymerich MS; Pérez-Manso M; Conte L; Combarro C; Roda E; Molina C; Gonzalo N; Castle M; Tuñón T; Erro E; Barroso-Chinea P
    Brain Res Bull; 2009 Feb; 78(2-3):55-9. PubMed ID: 18790023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The neuropsychology of nigrostriatal dopaminergic transmission in Parkinson's disease].
    Wallesch C
    Fortschr Neurol Psychiatr; 2011 Dec; 79(12):692-5. PubMed ID: 22009273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basal ganglia pathophysiology in Parkinson's disease.
    Montgomery EB
    Ann Neurol; 2009 May; 65(5):618; author reply 618-9. PubMed ID: 19475660
    [No Abstract]   [Full Text] [Related]  

  • 35. [Quantitative studies of neurons of the substantia nigra and basal ganglia in parkinsonism].
    Togi H; Ogawa M; Yamanouchi H; Tomonaga M; Kameyama M
    Rinsho Shinkeigaku; 1976 Apr; 16(4):311-8. PubMed ID: 986268
    [No Abstract]   [Full Text] [Related]  

  • 36. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
    Bezard E; Gross CE; Brotchie JM
    Trends Neurosci; 2003 Apr; 26(4):215-21. PubMed ID: 12689773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias).
    Barbeau A
    Neurotoxicology; 1984; 5(1):13-35. PubMed ID: 6538948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropathology of the basal ganglia in Parkinson's disease with a special reference to its responsible lesion].
    Tanaka J; Fukuda T
    Nihon Rinsho; 1997 Jan; 55(1):32-8. PubMed ID: 9014420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ Is Parkinson's disease due to deficiency of dopamine?].
    Castrén E
    Duodecim; 2005; 121(7):782-3; author reply 783-4. PubMed ID: 15909967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.